• Exchange: London
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

CRX:LN

5.5000 GBp 0.1250 2.33%

As of 11:30:00 ET on 04/17/2014.

Snapshot for Cyprotex PLC (CRX)

Open: 5.3750 Day's Range: 5.3750 - 5.5000 Volume: 0
Previous Close: 5.3750 52wk Range: 3.3750 - 13.0000 1-Yr Rtn: +51.72%

Stock Chart for CRX

No chart data available.
  • CRX:LN 5.5000
  • 1D
  • 1M
  • 1Y
5.3750
Interactive CRX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CRX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 27.5000
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) -0.0037
Est. EPS (GBP) (12/2014) 0.0020
Est. PEG Ratio -
Market Cap (M GBP) 12.34
Shares Outstanding (M) 224.34
30 Day Average Volume 292,252
Price/Book (mrq) 1.6592
Price/Sale (ttm) 1.2620
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CRX

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for CRX

Cyprotex plc is a drug discovery company. The Group uses experimental screening, virtual screening and discovery partnerships to identify pre-clinical drug candidates.

Anthony David Baxter "Tony"Chief Executive OfficerJohn Kevin DootsonChief Financial Officer
Mark Charles WarburtonCOO/Secretary/Legal CounselClive DilworthChief Scientific Officer
More Company Profile & Key Executives for CRX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement

Press Releases for CRX

Advertisement
Sponsored Links
Advertisements
sec ||= nil